ifenprodil has been researched along with Ache in 7 studies
ifenprodil: NMDA receptor antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intrathecal administration of 5 and 10 microg of NR2B subunit-specific NMDA receptor antagonist ifenprodil attenuated cancer-evoked spontaneous pain, thermal hyperalgesia and mechanical allodynia." | 3.76 | The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain. ( Gao, Q; Gu, X; Jin, Y; Ma, Z; Mei, F; Wang, J; Xia, X; Zhang, J; Zhou, X, 2010) |
| " Ifenprodil and some other NMDA antagonists (MK-801, memantine) were tested in a model of inflammatory pain (Randall-Selitto) in rats." | 3.71 | Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil. ( Chizh, BA; Englberger, W; Haase, G; Reissmüller, E; Scheede, M; Schlütz, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mony, L | 1 |
| Kew, JN | 1 |
| Gunthorpe, MJ | 1 |
| Paoletti, P | 1 |
| Gu, X | 1 |
| Zhang, J | 1 |
| Ma, Z | 1 |
| Wang, J | 1 |
| Zhou, X | 1 |
| Jin, Y | 1 |
| Xia, X | 1 |
| Gao, Q | 1 |
| Mei, F | 1 |
| Fischer, BD | 1 |
| Carrigan, KA | 1 |
| Dykstra, LA | 1 |
| Gogas, KR | 1 |
| Tan-No, K | 1 |
| Esashi, A | 1 |
| Nakagawasai, O | 1 |
| Niijima, F | 1 |
| Furuta, S | 1 |
| Sato, T | 1 |
| Satoh, S | 1 |
| Yasuhara, H | 1 |
| Tadano, T | 1 |
| Chizh, BA | 1 |
| Reissmüller, E | 1 |
| Schlütz, H | 1 |
| Scheede, M | 1 |
| Haase, G | 1 |
| Englberger, W | 1 |
| Green, GM | 1 |
| Gibb, AJ | 1 |
2 reviews available for ifenprodil and Ache
| Article | Year |
|---|---|
Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
Topics: Allosteric Regulation; Allosteric Site; Animals; Brain Diseases; Depressive Disorder, Major; Humans; | 2009 |
Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Topics: Animals; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Excitatory Amino Acid Ant | 2006 |
5 other studies available for ifenprodil and Ache
| Article | Year |
|---|---|
The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain.
Topics: Analysis of Variance; Animals; Behavior, Animal; Bone Neoplasms; Cell Line, Tumor; Cells, Cultured; | 2010 |
Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Topics: Analgesia; Analgesics, Opioid; Animals; Central Nervous System; Dose-Response Relationship, Drug; Dr | 2005 |
Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site.
Topics: 2-Amino-5-phosphonovalerate; Agmatine; Animals; Cycloserine; Dizocilpine Maleate; Dose-Response Rela | 2007 |
Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil.
Topics: Analgesics; Animals; Decerebrate State; Dizocilpine Maleate; Electric Stimulation; Excitatory Amino | 2001 |
Characterization of the single-channel properties of NMDA receptors in laminae I and II of the dorsal horn of neonatal rat spinal cord.
Topics: Aging; Animals; Excitatory Amino Acid Antagonists; Ion Channels; Magnesium; Membrane Potentials; N-M | 2001 |